In health the bladder contains at most a sparse, low-biomass microbiota that routine culture does not detect. The distal urethra is colonized by abundant flora. Any specimen collected through the urethra therefore contains some contaminating organisms, and culture must be quantitative to be interpretable. Specimen handling and urinalysis correlation are covered in Specimen Handling and Acceptability.1,2
Specimen collection
Scroll sideways to see all columns
| Method | Indication | Technique notes |
|---|---|---|
| Midstream clean-catch | Routine, ambulatory patients | Periurethral cleaning (women); initial urine stream discarded to flush urethral flora before the midstream portion is captured |
| Catheterization | Patient unable to produce a clean-catch specimen | First few milliliters discarded to clear catheter-tip contamination. Catheterization can introduce nosocomial infection, so it is used only when needed |
| Indwelling-catheter aspiration | Catheterized patients requiring culture | Disinfect the needleless sampling port and aspirate with a sterile syringe or cannula adapter; a legacy system without a needleless port is sampled through its disinfected port with a sterile needle and syringe, following the device manufacturer's instructions. Never sample from the collection bag.4 |
| Suprapubic aspiration | Neonates, or when urethral contamination must be entirely excluded | Needle puncture above the symphysis pubis into a full bladder. It bypasses urethral flora entirely, so any growth is potentially significant |
| Nephrostomy tube | Patients with a percutaneous nephrostomy for urinary diversion | Aspirate from the disinfected tube port or collect from fresh drainage. The tract is chronically colonized, so no colony-count threshold reliably separates colonization from infection. Interpret results together with the clinical picture. The same caveat applies to chronic indwelling (long-term) catheters and ileal conduits, both colonized by definition |
Process unpreserved urine within about 30 minutes at room temperature. When that is impossible, refrigerate the specimen at 2 to 8 °C for up to 24 hours or collect it into a boric-acid preservative tube. Both prevent the multiplication that falsely raises colony counts. For culture, the 2024 guidance of the Infectious Diseases Society of America and the American Society for Microbiology (IDSA/ASM) replaces the 2-hour room-temperature limit taught in older texts. Twenty-four-hour collections are unacceptable for culture. For urine parasitology (Schistosoma haematobium eggs), the preferred specimen is a terminal midday urine, collected when egg excretion peaks.2
Quantitative culture and colony-count interpretation
The routine setup is a blood agar plate paired with MacConkey or a chromogenic or colistin-nalidixic acid plate, incubated at 35 °C in ambient air and read at 16 to 24 hours, with negative plates incubated to 48 hours for slow growers. Quantitative culture uses a calibrated loop (0.001 mL for most specimens; 0.01 mL for suspected acute urethral syndrome in women and for suprapubic aspirates) streaked onto the agar so that colony counts translate directly into colony-forming units per milliliter:
CFU/mL = colonies counted × (1 ÷ loop volume in mL)
- 0.001 mL loop → multiply colony count by 1,000
- 0.01 mL loop → multiply colony count by 100
A 27-year-old woman with dysuria provides a midstream clean-catch urine. Using a 0.001-mL calibrated loop, the plate grows 156 colonies of one predominant lactose-fermenting gram-negative rod. CFU/mL = 156 × 1,000 = 156,000 CFU/mL (1.56 × 105 CFU/mL). This count meets the strictest criterion, ≥105 CFU/mL of one predominant organism in a voided specimen. In a symptomatic woman, a count as low as 102 to 103 CFU/mL of a uropathogen would also have supported the diagnosis.
A neonatal suprapubic aspirate is inoculated with a 0.01-mL loop and yields 11 colonies of a single organism. CFU/mL = 11 × 100 = 1,100 CFU/mL (1.1 × 103 CFU/mL). Because a suprapubic aspirate bypasses the urethral contamination expected with voided urine, even this low colony count is clinically meaningful when a single organism is recovered.
No single colony count separates infection from contamination in every specimen. The classic ≥105 CFU/mL criterion (Kass) was derived from screening asymptomatic women and is now used mainly to define asymptomatic bacteriuria: the same organism at ≥105 CFU/mL in two consecutive voided specimens from a woman, or one specimen from a man. Symptomatic infection occurs at lower counts. As few as 102 to 103 CFU/mL of a single uropathogen can be significant in a symptomatic woman, ≥103 CFU/mL in a symptomatic man or a straight-catheter specimen, and any growth from a suprapubic aspirate warrants workup. Growth of three or more organism types at low counts usually means periurethral contamination. Report it as mixed flora and do not work it up. Your laboratory's culture algorithm sets workup thresholds by collection method and patient population. Screening for asymptomatic bacteriuria is limited to pregnancy and planned urologic procedures that breach mucosa.
Screening methods
Dipstick chemistry combines nitrite (a byproduct of bacterial nitrate reductase, an enzyme most gram-negative uropathogens express) and leukocyte esterase (a neutrophil enzyme that indicates pyuria). When both are negative, infection is unlikely in patients with a low pretest probability, so the dipstick is useful for screening specimens before culture. It cannot rule out urinary tract infection (UTI) in a symptomatic patient, and nitrite is falsely negative when the organism lacks nitrate reductase (enterococci, S. saprophyticus, most Acinetobacter) or when urine has not incubated in the bladder for the several hours the reduction requires. Gram stain of uncentrifuged urine is economical but too labor-intensive for routine high-volume screening. The presence of ≥1 organism per oil-immersion field correlates well with ≥105 CFU/mL. Automated instrument screening (flow cytometry or particle-counting platforms) rapidly excludes specimens unlikely to grow a clinically significant count, improving turnaround for specimens that do require culture.
Urine is an acceptable nucleic acid amplification test (NAAT) specimen for Neisseria gonorrhoeae and Chlamydia trachomatis. Molecular testing is standard for BK virus and is commonly used to detect cytomegalovirus (CMV), adenovirus, and herpes simplex virus (HSV) in urine. For BK virus, plasma quantitative polymerase chain reaction (PCR) guides transplant management. Detection of BK virus in urine is common and less specific. Leptospira interrogans is detectable in urine from the second week of illness onward using specialized enriched semisolid media, but the organism dies quickly in acidic urine, so the specimen must be processed promptly. Culture is insensitive and slow, so NAAT and serology (the microscopic agglutination test) are the primary diagnostics.
Identification of common urinary pathogens
Scroll sideways to see all columns
| Organism | Colony morphology and key reactions in urine culture | Confirmatory test(s) | Clinical context |
|---|---|---|---|
| Staphylococcus saprophyticus | White to yellow colonies on blood agar, often slightly larger than other coagulase-negative staphylococci | Coagulase-negative; novobiocin-resistant on a 5-µg disk, the defining test separating it from other coagulase-negative staphylococci (CoNS) | Second most common cause of uncomplicated cystitis after E. coli, chiefly in young, sexually active women |
| Enterococcus spp. | Small, gray, nonhemolytic or alpha-hemolytic colonies | PYR-positive, bile-esculin-positive, growth in 6.5% NaCl broth | Catheter-associated and complicated UTI; intrinsic low-level resistance to many agents |
| Streptococcus agalactiae (group B) | Narrow-zone beta-hemolytic colonies | Hippurate hydrolysis-positive, CAMP test (Christie-Atkins-Munch-Petersen) positive | Laboratories report group B Streptococcus (GBS) in prenatal urine at any colony count; documented GBS bacteriuria at any count makes the patient a candidate for intrapartum antibiotic prophylaxis regardless of later screening-culture results, and ≥105 CFU/mL is also treated during pregnancy as asymptomatic bacteriuria5 |
| Enterobacterales (E. coli, Klebsiella, Proteus, and others) | Lactose-fermenting, pink colonies on MacConkey (E. coli, Klebsiella); Proteus swarms and is lactose-negative | Full biochemical differentiation as in enteric bacteriology | E. coli causes the large majority of community-acquired UTI; Klebsiella and Proteus follow |
| Candida spp. | White to cream, smooth, yeast-odored colonies on blood or urine-culture agar | Germ tube test (presumptive; C. albicans and C. dubliniensis are both positive) or chromogenic agar for presumptive species identification; a validated method such as matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry confirms the species when species resolution matters | Candiduria is frequently catheter-associated and often represents colonization |
Novobiocin susceptibility here is an identification test with its own interpretive criteria. Zone sizes for the 5-µg disk come from the disk manufacturer's instructions. Report the isolate as S. saprophyticus when the laboratory's validated identification method supports that identification.1
Phenotypic and biochemical identification
Identification begins with Gram-stain morphology and colony appearance, including pigmentation, hemolysis, odor, swarming, and mucoidy. Spot tests follow, chosen by organism group: oxidase, catalase, indole, urease, and hippurate hydrolysis. An oxidase-negative result supports Enterobacterales except Plesiomonas, the order's only oxidase-positive member. Oxidase-positive gram-negative rods include Vibrio, Aeromonas, Campylobacter, and Pasteurella. Conventional biochemical panels such as triple sugar iron, motility-indole-urease, Simmons citrate, and decarboxylase broths remain the reference method for definitive identification when automated or molecular methods are unavailable or give a discordant result. Commercial manual or semi-automated systems use miniaturized panels of dried or lyophilized substrates read after overnight incubation. They are routinely used for bench identification, with good accuracy for common Enterobacterales and higher throughput than fully manual biochemicals.
Coagulase. Coagulase is the classic test separating Staphylococcus aureus from coagulase-negative staphylococci. The slide (rapid) test detects bound coagulase (clumping factor), which binds fibrinogen directly and causes visible clumping within 10 seconds when a colony is emulsified in plasma on a slide. The slide test is rapid. It does not detect free coagulase, so it gives occasional false negatives. The tube test detects free coagulase, a secreted enzyme that complexes with coagulase-reacting factor, a prothrombin-like plasma protein. The complex converts fibrinogen to fibrin. A colony suspension in plasma is incubated at 35 °C and examined for any degree of clot formation at 4 hours, with a negative 4-hour result reincubated and re-read at 24 hours because some strains clot slowly. Confirm a slide-negative isolate with typical S. aureus colony morphology and beta-hemolysis by the tube test. Essentially all S. aureus strains are eventually tube-positive, and only about 80 to 90% are slide-positive. S. lugdunensis and S. schleiferi also produce clumping factor and can be slide-positive and tube-negative. Use the tube test to resolve both discrepancies.
PYR (L-pyrrolidonyl-β-naphthylamide hydrolysis). The organism is inoculated onto a PYR-impregnated disk or into broth. When pyrrolidonyl arylamidase is present, it hydrolyzes the substrate and releases β-naphthylamine, which turns red within 1 to 2 minutes after p-dimethylaminocinnamaldehyde reagent is added. Enterococcus spp. and Streptococcus pyogenes (group A Streptococcus) are PYR-positive. Other beta-hemolytic streptococci, including group B, and viridans-group streptococci are PYR-negative. Leuconostoc and Pediococcus, lactic-acid bacteria sometimes mistaken for streptococci, are also PYR-negative. PYR is therefore used to separate group A streptococci from other beta-hemolytic streptococci at the bench, and to separate enterococci from group D streptococci (S. gallolyticus and relatives), which the older bile-esculin and 6.5% NaCl tests do not always separate reliably.
X and V factor requirements. Haemophilus spp. require hemin (X factor, a heat-stable, iron-containing porphyrin), nicotinamide adenine dinucleotide (NAD; V factor, a heat-labile coenzyme), or both for growth, and the requirement pattern supports a presumptive identification. X- and V-factor-impregnated paper strips or a quadrant plate streaked with X, V, and X+V disks are placed on unsupplemented (non-chocolate) medium. Growth only around the combined X+V disk supports a presumptive identification of H. influenzae, which requires both factors, but H. haemolyticus shares that pattern, so hemolysis on horse blood agar or a validated identification method separates them. Growth around the V disk alone gives only a presumptive identification of H. parainfluenzae, because other V-dependent species share the pattern. H. ducreyi requires X factor only. The porphyrin test replaces the X strip. It detects conversion of delta-aminolevulinic acid to porphyrins, a pathway present only in organisms that synthesize their own heme, so a positive test means the organism does not require exogenous X factor. Satellitism is a simpler bench test. Sheep blood agar does not supply free V factor because NAD is bound and inactivated by an enzyme in sheep erythrocytes. On this medium, X/V-dependent Haemophilus grows only as tiny colonies clustered around a streak of Staphylococcus aureus, whose hemolysis releases NAD locally.
Neisseria and Moraxella carbohydrate utilization. Cystine trypticase agar (CTA) sugars differentiate oxidase-positive, gram-negative diplococci by acid production. Glucose, maltose, lactose, and sucrose are each tested in a separate tube with a pH indicator. N. gonorrhoeae acidifies glucose only; N. meningitidis acidifies glucose and maltose; N. lactamica acidifies glucose, maltose, and lactose; and Moraxella catarrhalis acidifies none of the four. Positive DNase and butyrate esterase (indoxyl butyrate) spot tests confirm M. catarrhalis and distinguish it from CTA-negative Neisseria species that lack these enzymes.
Mass spectrometry (MALDI-TOF)
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identifies organisms from the mass profile of their abundant ribosomal proteins. A colony, or a formic-acid extract for gram-positive organisms and fungi, is overlaid with an acidic matrix, most often α-cyano-4-hydroxycinnamic acid dissolved in an acetonitrile-water-trifluoroacetic acid solvent that penetrates the cell and releases intracellular protein. The matrix absorbs the laser pulse and ionizes the proteins, producing a protein mass fingerprint of roughly 2 to 20 kDa that is matched against a reference database. MALDI-TOF is fast, inexpensive per test after capital investment, and reliably identifies most Enterobacterales, nonfermenters, staphylococci, and anaerobes. It cannot reliably distinguish Shigella from E. coli, or Streptococcus pneumoniae from its closest mitis-group relatives, without supplemental testing, and it requires growth in pure culture.
Molecular detection: target selection and amplification
Conserved sequences shared broadly across taxa cross-react, so they are used for broad-range detection. Universal bacterial detection by 16S rRNA gene sequencing uses conserved regions to anchor primer binding and hypervariable regions to provide genus/species discrimination. Sequence-unique regions are used for species- or serotype-specific detection. Most routine testing uses commercial platforms cleared by the Food and Drug Administration (FDA), with prevalidated primers and probes. Laboratory-developed tests fill gaps where no cleared assay exists but require local validation.
Amplification and detection formats relevant to bacteriology include real-time (quantitative) PCR, transcription-mediated amplification, loop-mediated isothermal amplification, and strand-displacement amplification. Real-time PCR monitors amplification in a closed tube, which reduces amplicon carryover contamination. The assay's validated reporting format determines whether it provides a qualitative result or a quantitative measurement. Detection alone cannot separate colonization from disease. For example, the Centers for Disease Control and Prevention (CDC) notes that molecular tests for Clostridioides difficile can be positive in people without infection.3 Post-amplification melt-curve analysis measures the temperature at which a double-stranded amplicon dissociates, detected as a drop in fluorescence. This allows genotyping without opening the reaction tube and is useful for distinguishing closely related targets that share an amplification target region.
Molecular epidemiology and strain typing
Reference laboratories compare isolates from different patients, sites, or times during outbreak investigations. Whole-genome sequencing has largely replaced pulsed-field gel electrophoresis as the typing method of choice because it resolves strain relatedness at single-nucleotide level. Interpret every urine colony count with the collection method. The same count has a different meaning in a voided specimen and in a suprapubic aspirate.
References
- Tille PM. Bailey & Scott's Diagnostic Microbiology. 15th ed. Elsevier; 2021. Back to text
- Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. Published online March 5, 2024. doi:10.1093/cid/ciae104 Full-text PDF: Accessed September 17, 2026. https://www.idsociety.org/globalassets/idsa/practice-guidelines/ciae104.pdf Section XI, Urinary Tract Infections, key points (p. 119): "Urine collected for culture should not be kept at room temperature for more than 30 minutes. Hold at refrigerator temperatures or utilize a preservative tube if not processed by the laboratory within 30 minutes." The cystitis and pyelonephritis text (p. 120) gives the standardized threshold in symptomatic patients as more than 100,000 CFU/mL, with 10,000 or 1,000 CFU/mL used by many sites according to collection method and patient population. Table 38 (p. 123) directs refrigeration at 4 °C or a preservative transport tube when delivery to the laboratory exceeds 1 hour. Back to text
- Centers for Disease Control and Prevention. Clinical testing and diagnosis for C. diff infection. March 6, 2024. Molecular tests. Accessed September 7, 2026. https://www.cdc.gov/c-diff/hcp/diagnosis-testing/index.html Back to text
- Centers for Disease Control and Prevention. Catheter-associated urinary tract infections (CAUTI): summary of recommendations. March 25, 2024. Recommendation III.U.1 (Category IB): "If a small volume of fresh urine is needed for examination (i.e., urinalysis or culture), aspirate the urine from the needleless sampling port with a sterile syringe/cannula adapter after cleansing the port with a disinfectant." Accessed September 13, 2026. https://www.cdc.gov/infection-control/hcp/cauti/summary-of-recommendations.html Back to text
- Filkins L, Hauser J, Robinson-Dunn B, et al. Guidelines for the detection and identification of group B Streptococcus. American Society for Microbiology; updated July 23, 2021. Recommendation: report GBS in any quantity from urine cultures from pregnant women during all trimesters. Accessed September 24, 2026. https://asm.org/getcontentasset/87c90ce7-5cef-4191-9c36-529b1212242a/dfc3d011-8f63-43f6-9ed8-4b444333a1d0/asm-gbs-guideline.pdf Back to text